Download PDF
Semin intervent Radiol 2008; 25(3): 216-233
DOI: 10.1055/s-0028-1085921
© by Thieme Medical Publishers

Imaging and Percutaneous Treatment of Vascular Anomalies

Sandeep Vaidya1 , Daniel Cooke1 , Matthew Kogut1 , Peter G. Stratil1 , Mark A. Bittles2 , Manrita Sidhu3
  • 1Department of Radiology, University of Washington, Seattle, Washington
  • 2Vanderbilt University and Vanderbilt Children's Hospital, Nashville, Tennessee
  • 3Children's Hospital and Regional Medical Center, University of Washington, Seattle Radiologists Advanced Imaging Center, Everett, Washington
Further Information

Publication History

Publication Date:
30 September 2008 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Vascular anomalies are an extensive group of malformations of the arterial, venous, and lymphatic systems, either in isolation or, more often, in combination. Although mostly congenital, they can occasionally be acquired as well. They present a challenge both for workup and therapy. This article attempts to describe some of their main anomalies, their workup, and their therapies, with the goal of increasing the comfort level of endovascular therapists.

KEYWORDS

Vascular anomalies - malformations - hemangiomas - percutaneous endovascular therapy - embolization

REFERENCES

  • 1 Mulliken J B, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.  Plast Reconstr Surg. 1982;  69(3) 412-422
    CrossrefPubMedGoogle Scholar
  • 2 JK W, TS L, CT R et al. For hemangiomas refractory to first line corticosteroid therapy, interferon and vincristine therapy has been described. In, International Society for the Study of Vascular Anomalies. Wellington, New Zealand; 2004
    Google Scholar
  • 3 Chang M W. Updated classification of hemangiomas and other vascular anomalies.  Lymphat Res Biol. 2003;  1(4) 259-265
    CrossrefPubMedGoogle Scholar
  • 4 Upton J, Coombs C J, Mulliken J B, Burrows P E, Pap S. Vascular malformations of the upper limb: a review of 270 patients.  J Hand Surg [Am]. 1999;  24(5) 1019-1035
    PubMedGoogle Scholar
  • 5 Cho S K, Do Y S, Shin S W, Kim D I et al.. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification.  J Endovasc Ther. 2006;  13 527-538
    CrossrefPubMedGoogle Scholar
  • 6 Jacobowitz G, Rosen R J, Rockman C B et al.. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up.  J Vasc Surg. 2001;  33(1) 51-55
    CrossrefPubMedGoogle Scholar
  • 7 Hadizadeh D R, von Falkenhausen M, Gieseke J et al.. Cerebral arteriovenous malformation: Spetzler-Martin classification at subsecond-temporal-resolution four-dimensional MR angiography compared with that at DSA.  Radiology. 2008;  246(1) 205-213
    CrossrefPubMedGoogle Scholar
  • 8 Bittles M A, Sidhu M K, Sze R W et al.. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: utility of 3-D reformatting in differential diagnosis.  Pediatr Radiol. 2005;  35(11) 1100-1106
    CrossrefPubMedGoogle Scholar
  • 9 Ohgiya Y, Hashimoto T, Gokan T. Dynamic MRI for Distinguishing High-flow from Low-flow peripheral vascular malformations.  AJR Am J Roentgenol. 2005;  185(5) 1131-1137
    CrossrefPubMedGoogle Scholar
  • 10 Lee B B, Do Y S, Yakes W, Kim D I, Mattassi R, Hyon W S. Management of arteriovenous malformations: a multidisciplinary approach.  J Vasc Surg. 2004;  39(3) 590-600
    CrossrefPubMedGoogle Scholar
  • 11 Do Y S, Yakes W F, Shin S W et al.. ethanol embolization of arteriovenous malformations: interim results.  Radiology. 2005;  235(2) 674-682
    CrossrefPubMedGoogle Scholar
  • 12 Jordan O, Doelker E, Rufenacht D A. Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces.  Cardiovasc Intervent Radiol. 2005;  28(5) 561-569
    CrossrefPubMedGoogle Scholar
  • 13 Osuga K, Hori S, Kitayoshi H et al.. Embolization of high flow arteriovenous malformations: experience with use of superabsorbent polymer microspheres.  J Vasc Interv Radiol. 2002;  13(11) 1125-1133
    PubMedGoogle Scholar
  • 14 Yakes W F, Haas D K, Parker S H et al.. Symptomatic vascular malformations: ethanol embolotherapy.  Radiology. 1989;  170(3 Pt 2) 1059-1066
    CrossrefPubMedGoogle Scholar
  • 15 White Jr R I, Pollak J, Persing J et al.. Long-term outcome of embolotherapy and surgery for high-flow extremity arteriovenous malformations.  J Vasc Interv Radiol. 2000;  11(10) 1285-1295
    CrossrefPubMedGoogle Scholar
  • 16 Vikkula M, Boon L, Mulliken J. Molecular genetics of vascular malformations.  Matrix Biol. 2001;  20(5–6) 327-335
    CrossrefPubMedGoogle Scholar
  • 17 Burrows P E, Mason K P. Percutaneous treatment of low flow vascular malformations.  J Vasc Interv Radiol. 2004;  15(5) 431-445
    CrossrefPubMedGoogle Scholar
  • 18 Claudon M, Upton J, Burrows P. Diffuse venous malformations of the upper limb: morphologic characterization by MRI and venography.  Pediatr Radiol. 2001;  31(7) 507-514
    CrossrefPubMedGoogle Scholar
  • 19 Ohlms L A, Forsen J, Burrows P E. Venous malformation of the pediatric airway.  Int J Pediatr Otorhinolaryngol. 1996;  37(2) 99-114
    CrossrefPubMedGoogle Scholar
  • 20 Mason K P, Neufeld E J, Karian V E et al.. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.  AJR Am J Roentgenol. 2001;  177(6) 1359-1363
    PubMedGoogle Scholar
  • 21 van Rijswijk C S, van der Linden E, van der Woude H J, van Baalen J M, Bloem J L. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations.  AJR Am J Roentgenol. 2002;  178(5) 1181-1187
    CrossrefPubMedGoogle Scholar
  • 22 Dobson M J, Hartley R W, Ashleigh R, Watson Y, Hawnaur J M. MR angiography and MR imaging of symptomatic vascular malformations.  Clin Radiol. 1997;  52(8) 595-602
    CrossrefPubMedGoogle Scholar
  • 23 Kim E Y, Ahn J M, Yoon H K et al.. Intramuscular vascular malformations of an extremity: findings on MR imaging and pathologic correlation.  Skeletal Radiol. 1999;  28(9) 515-521
    CrossrefPubMedGoogle Scholar
  • 24 Herborn C U, Goyen M, Lauenstein T C et al.. Comprehensive time-resolved MRI of peripheral vascular malformations.  AJR Am J Roentgenol. 2003;  181(3) 729-735
    PubMedGoogle Scholar
  • 25 Rak K M, Yakes W F, Ray R L et al.. MR imaging of symptomatic peripheral vascular malformations.  AJR Am J Roentgenol. 1992;  159(1) 107-112
    PubMedGoogle Scholar
  • 26 Meyer J S, Hoffer F A, Barnes P D, Mulliken J B. Biological classification of soft-tissue vascular anomalies: MR correlation.  AJR Am J Roentgenol. 1991;  157(3) 559-564
    CrossrefPubMedGoogle Scholar
  • 27 Buchta K, Sands J, Rosenkrantz H, Roche W. Early mechanism of action of arterially infused alcohol U.S.P. in renal devitalization.  Radiology. 1982;  145(1) 45-48
    PubMedGoogle Scholar
  • 28 Anadon M J, Almendral J, González P et al.. Alcohol concentration determines the type of atrial arrhythmia induced in a porcine model of acute alcoholic intoxication.  Pacing Clin Electrophysiol. 1996;  19(11 Pt 2) 1962-1967
    PubMedGoogle Scholar
  • 29 Chi L M, Wu W G. Mechanism of hemolysis of red blood cell mediated by ethanol.  Biochim Biophys Acta. 1991;  1062(1) 46-50
    PubMedGoogle Scholar
  • 30 Behnia R. Systemic effects of absolute alcohol embolization in a patient with a congenital arteriovenous malformation of the lower extremity.  Anesth Analg. 1995;  80(2) 415-417
    CrossrefPubMedGoogle Scholar
  • 31 Berenguer B, Burrows P, Zurakowski D, Mulliken J. Sclerotherapy of craniofacial venous malformations: complications and results.  Plast Reconstr Surg. 1999;  104(1) 1-11 discussion 12-15
    PubMedGoogle Scholar
  • 32 Lee B B, Do Y S, Byun H S et al.. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.  J Vasc Surg. 2003;  37(3) 533-538
    CrossrefPubMedGoogle Scholar
  • 33 Mitchell S E, Shah A M, Schwengel D. Pulmonary artery pressure changes during ethanol embolization procedures to treat vascular malformations: can cardiovascular collapse be predicted?.  J Vasc Interv Radiol. 2006;  17(2 Pt 1) 253-262
    PubMedGoogle Scholar
  • 34 Siniluoto T M, Svendsen P A, Wikholm G M, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (Sotradecol).  Scand J Plast Reconstr Surg Hand Surg. 1997;  31(2) 145-150
    CrossrefPubMedGoogle Scholar
  • 35 de Lorimier A A. Sclerotherapy for venous malformations.  J Pediatr Surg. 1995;  30(2) 188-193 discussion 194
    CrossrefPubMedGoogle Scholar
  • 36 Cabrera J, Cabrera J J, Garcia-Olmedo M. Sclerosants in microfoam. A new approach in angiology.  Int Angiol. 2001;  20(4) 322-329
    PubMedGoogle Scholar
  • 37 Sidhu M K, Perkins J A, Shaw D W, Bittles M A, Andrews R T. Ultrasound-guided endovenous diode laser in the treatment of congenital venous malformations: preliminary experience.  J Vasc Interv Radiol. 2005;  16(6) 879-884
    PubMedGoogle Scholar
  • 38 van der Linden E, Overbosch J, Kroft L. Radiofrequency ablation for treatment of symptomatic low-flow vascular malformations after previous unsuccessful therapy.  J Vasc Interv Radiol. 2005;  16(5) 747-750
    PubMedGoogle Scholar
  • 39 Belov S. Anatomopathological classification of congenital vascular defects.  Semin Vasc Surg. 1993;  6(4) 219-224
    PubMedGoogle Scholar
  • 40 Lee B B, Kim Y W, Seo J M et al.. Current concepts in lymphatic malformation.  Vasc Endovascular Surg. 2005;  39(1) 67-81
    CrossrefPubMedGoogle Scholar
  • 41 Mulliken J B, Fishman S J, Burrows P E. Vascular anomalies.  Curr Probl Surg. 2000;  37(8) 517-584
    CrossrefPubMedGoogle Scholar
  • 42 Alomari A I, Karian V E, Lord D J, Padua H M, Burrows P E. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement.  J Vasc Interv Radiol. 2006;  17(10) 1639-1648
    CrossrefPubMedGoogle Scholar
  • 43 Sanlialp I, Karnak I, Tanyel F, Senocak M, Büyükpamukçu N. Sclerotherapy for lymphangioma in children.  Int J Pediatr Otorhinolaryngol. 2003;  67(7) 795-800
    CrossrefPubMedGoogle Scholar
  • 44 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.  Radiology. 1997;  204(3) 651-654
    CrossrefPubMedGoogle Scholar
  • 45 Ogita S, Tsuto T, Deguchi E et al.. OK-432 therapy for unresectable lymphangiomas in children.  J Pediatr Surg. 1991;  26(3) 263-268 discussion 268-270
    CrossrefPubMedGoogle Scholar
  • 46 Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children.  Eur Arch Otorhinolaryngol. 2002;  259(5) 274-278
    CrossrefPubMedGoogle Scholar
  • 47 Molitch H I, Unger E C, Witte C L, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas.  Radiology. 1995;  194(2) 343-347
    CrossrefPubMedGoogle Scholar
  • 48 Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma.  J Pediatr Surg. 1995;  30(9) 1282-1287
    CrossrefPubMedGoogle Scholar
  • 49 Shiels 2nd W E, Kenney B, Caniano D, Besner G. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.  J Pediatr Surg. 2008;  43(1) 136-139 discussion 140
    CrossrefPubMedGoogle Scholar
  • 50 Burrows P E, Laor T, Paltiel H, Robertson R L. Diagnostic imaging in the evaluation of vascular birthmarks.  Dermatol Clin. 1998;  16(3) 455-488
    CrossrefPubMedGoogle Scholar
  • 51 Fishman S J, Mulliken J B. Hemangiomas and vascular malformations of infancy and childhood.  Pediatr Clin North Am. 1993;  40(6) 1177-1200
    PubMedGoogle Scholar
  • 52 Haggstrom A N, Drolet B A Hemangioma Investigator Group et al.. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.  J Pediatr. 2007;  150(3) 291-294
    CrossrefPubMedGoogle Scholar
  • 53 Frieden I J, Haggstrom A N, Drolet B A et al.. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, Maryland, USA.  Pediatr Dermatol. 2005;  22(5) 383-406
    CrossrefPubMedGoogle Scholar
  • 54 Haggstrom A N, Drolet B A, Baselga E et al.. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.  Pediatrics. 2006;  118(3) 882-887
    CrossrefPubMedGoogle Scholar
  • 55 Ezekowitz R A, Mulliken J B, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.  N Engl J Med. 1992;  326(22) 1456-1463
    CrossrefPubMedGoogle Scholar
  • 56 Fishman S J, Burrows P E, Leichtner A M, Mulliken J B. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities.  J Pediatr Surg. 1998;  33(7) 1163-1167
    CrossrefPubMedGoogle Scholar
  • 57 Achauer B M, Chang C J, Vander Kam V M. Management of hemangioma of infancy: review of 245 patients.  Plast Reconstr Surg. 1997;  99(5) 1301-1308
    PubMedGoogle Scholar
  • 58 Laor T, Jaramillo D, Hoffer F, Kasser J. MR imaging in congenital lower limb deformities.  Pediatr Radiol. 1996;  26(6) 381-387
    CrossrefPubMedGoogle Scholar
  • 59 Enjolras O, Wassef M, Mazoyer E et al.. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas.  J Pediatr. 1997;  130(4) 631-640
    PubMedGoogle Scholar
  • 60 Berenguer B, Mulliken J, Enjolras O et al.. Rapidly involuting congenital hemangioma: clinical and histopathologic features.  Pediatr Dev Pathol. 2003;  6(6) 495-510
    CrossrefPubMedGoogle Scholar
  • 61 Enjolras O, Mulliken J, Boon L et al.. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly.  Plast Reconstr Surg. 2001;  107(7) 1647-1654
    CrossrefPubMedGoogle Scholar
  • 62 Donnelly L F, Adams D M, Bisset G S. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic.  AJR Am J Roentgenol. 2000;  174(3) 597-608
    CrossrefPubMedGoogle Scholar
  • 63 Dubois J, Patriquin H, Garel L et al.. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography.  AJR Am J Roentgenol. 1998;  171(1) 247-252
    CrossrefPubMedGoogle Scholar
  • 64 Hovius S E, Borg D H, Paans P R, Pieterman H. The diagnostic value of magnetic resonance imaging in combination with angiography in patients with vascular malformations: a prospective study.  Ann Plast Surg. 1996;  37(3) 278-285
    PubMedGoogle Scholar
  • 65 Kern S, Niemeyer C, Darge K et al.. Differentiation of vascular birthmarks by MR imaging. An investigation of hemangiomas, venous and lymphatic malformations.  Acta Radiol. 2000;  41(5) 453-457
    CrossrefPubMedGoogle Scholar
  • 66 Konez O, Burrows P, Mulliken J, Fishman S, Kozakewich H. Angiographic features of rapidly involuting congenital hemangioma (RICH).  Pediatr Radiol. 2003;  33(1) 15-19
    CrossrefPubMedGoogle Scholar
  • 67 Laor T, Burrows P. Congenital anomalies and vascular birthmarks of the lower extremities.  Magn Reson Imaging Clin N Am. 1998;  6(3) 497-519
    PubMedGoogle Scholar
  • 68 Chamlin S, Haggstrom A, Drolet B et al.. Multicenter prospective study of ulcerated hemangiomas.  J Pediatr. 2007;  151(6) 684-689
    PubMedGoogle Scholar
  • 69 Amir J, Metzker A, Krikler R, Reisner S. Strawberry hemangioma in preterm infants.  Pediatr Dermatol. 1986;  3(4) 331-332
    CrossrefPubMedGoogle Scholar
  • 70 Jacobs A H, Walton R G. The incidence of birthmarks in the neonate.  Pediatrics. 1976;  58(2) 218-222
    PubMedGoogle Scholar
  • 71 Boye E, Yu Y, Paranya G et al.. Clonality and altered behavior of endothelial cells from hemangiomas.  J Clin Invest. 2001;  107(6) 745-752
    CrossrefPubMedGoogle Scholar
  • 72 Walter J W, North P E, Waner M et al.. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma.  Genes Chromosomes Cancer. 2002;  33(3) 295-303
    CrossrefPubMedGoogle Scholar
  • 73 North P E, Waner M, Mizeracki A, Mihm M C. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.  Hum Pathol. 2000;  31(1) 11-22
    CrossrefPubMedGoogle Scholar
  • 74 North P E, Waner M, Mizeracki A et al.. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.  Arch Dermatol. 2001;  137(5) 559-570
    PubMedGoogle Scholar
  • 75 Yu Y, Flint A, Mulliken J, Wu J, Bischoff J. Endothelial progenitor cells in infantile hemangioma.  Blood. 2004;  103(4) 1373-1375
    PubMedGoogle Scholar
  • 76 Dubois J, Milot J, Jaeger B et al.. Orbit and eyelid hemangiomas: is there a relationship between location and ocular problems?.  J Am Acad Dermatol. 2006;  55(4) 614-619
    CrossrefPubMedGoogle Scholar
  • 77 Haik B G, Jakobiec F A, Ellsworth R M, Jones I S. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases.  Ophthalmology. 1979;  86(5) 760-792
    PubMedGoogle Scholar
  • 78 Stigmar G, Crawford J, Ward C, Thomson H. Ophthalmic sequelae of infantile hemangiomas of the eyelids and orbit.  Am J Ophthalmol. 1978;  85(6) 806-813
    CrossrefPubMedGoogle Scholar
  • 79 Enjolras O, Riche M, Merland J, Escande J. Management of alarming hemangiomas in infancy: a review of 25 cases.  Pediatrics. 1990;  85(4) 491-498
    PubMedGoogle Scholar
  • 80 Rahbar R, Nicollas R, Roger G et al.. The biology and management of subglottic hemangioma: past, present, future.  Laryngoscope. 2004;  114(11) 1880-1891
    CrossrefPubMedGoogle Scholar
  • 81 Bitar M A, Moukarbel R V, Zalzal G H. Management of congenital subglottic hemangioma: trends and success over the past 17 years.  Otolaryngol Head Neck Surg. 2005;  132(2) 226-231
    CrossrefPubMedGoogle Scholar
  • 82 Christison-Lagay E R, Burrows P E, Alomari A et al.. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry.  J Pediatr Surg. 2007;  42(1) 62-67 discussion 67-68
    CrossrefPubMedGoogle Scholar
  • 83 Burrows P E, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies.  Pediatr Radiol. 2001;  31(8) 533-545
    PubMedGoogle Scholar
  • 84 Boon L M, Burrows P E, Paltiel H J et al.. Hepatic vascular anomalies in infancy: a twenty-seven-year experience.  J Pediatr. 1996;  129(3) 346-354
    CrossrefPubMedGoogle Scholar
  • 85 Kassarjian A, Dubois J, Burrows P E. Angiographic classification of hepatic hemangiomas in infants.  Radiology. 2002;  222(3) 693-698
    CrossrefPubMedGoogle Scholar
  • 86 Kassarjian A, Zurakowski D, Dubois J et al.. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy.  AJR Am J Roentgenol. 2004;  182(3) 785-795
    CrossrefPubMedGoogle Scholar
  • 87 Albright A L, Gartner J C, Wiener E S. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords.  Pediatrics. 1989;  83(6) 977-980
    PubMedGoogle Scholar
  • 88 Burke D R, Verstandig A, Edwards O et al.. Infantile hemangioendothelioma: angiographic features and factors determining efficacy of hepatic artery embolization.  Cardiovasc Intervent Radiol. 1986;  9(3) 154-157
    CrossrefPubMedGoogle Scholar
  • 89 Fishman S J, Mulliken J B. Vascular anomalies. A primer for pediatricians.  Pediatr Clin North Am. 1998;  45(6) 1455-1477
    CrossrefPubMedGoogle Scholar
  • 90 Pope E, Krafchik B, Macarthur C et al.. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial.  Pediatrics. 2007;  119(6) e1239-e1247
    CrossrefPubMedGoogle Scholar
  • 91 Al-Sebeih K, Manoukian J. Systemic steroids for the management of obstructive subglottic hemangioma.  J Otolaryngol. 2000;  29(6) 361-366
    PubMedGoogle Scholar
  • 92 Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisone.  J Pediatr. 1996;  128(1) 141-146
    PubMedGoogle Scholar
  • 93 Boon L M, MacDonald D M, Mulliken J B. Complications of systemic corticosteroid therapy for problematic hemangioma.  Plast Reconstr Surg. 1999;  104(6) 1616-1623
    CrossrefPubMedGoogle Scholar
  • 94 George M E, Sharma V, Jacobson J, Simon S, Nopper A J. Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas.  Arch Dermatol. 2004;  140(8) 963-969
    CrossrefPubMedGoogle Scholar
  • 95 Kushner B J. The treatment of periorbital infantile hemangioma with intralesional corticosteroid.  Plast Reconstr Surg. 1985;  76(4) 517-526
    CrossrefPubMedGoogle Scholar
  • 96 Sloan G M, Reinisch J F, Nichter L S et al.. Intralesional corticosteroid therapy for infantile hemangiomas.  Plast Reconstr Surg. 1989;  83(3) 459-467
    CrossrefPubMedGoogle Scholar
  • 97 Greinwald J H, Burke D K, Bonthius D J, Bauman N M, Smith R J. An update on the treatment of hemangiomas in children with interferon alfa-2a.  Arch Otolaryngol Head Neck Surg. 1999;  125(1) 21-27
    PubMedGoogle Scholar
  • 98 Enjolras O, Brevière G M, Roger G et al.. Vincristine treatment for function- and life-threatening infantile hemangioma.  Arch Pediatr. 2004;  11(2) 99-107
    CrossrefPubMedGoogle Scholar
  • 99 Perez J, Pardo J, Gomez C. Vincristine–an effective treatment of corticoid-resistant life-threatening infantile hemangiomas.  Acta Oncol. 2002;  41(2) 197-199
    PubMedGoogle Scholar
  • 100 Fawcett S L, Grant I, Hall P N, Kelsall A W, Nicholson J C. Vincristine as a treatment for a large haemangioma threatening vital functions.  Br J Plast Surg. 2004;  57(2) 168-171
    CrossrefPubMedGoogle Scholar
  • 101 David L R, Malek M M, Argenta L C. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients.  Br J Plast Surg. 2003;  56(4) 317-327
    CrossrefPubMedGoogle Scholar
  • 102 Gupta G, Bilsland D. A prospective study of the impact of laser treatment on vascular lesions.  Br J Dermatol. 2000;  143(2) 356-359
    CrossrefPubMedGoogle Scholar
  • 103 Poetke M, Philipp C, Berlien H. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas.  Arch Dermatol. 2000;  136(5) 628-632
    CrossrefPubMedGoogle Scholar
  • 104 Waner M, Suen J, Dinehart S, Mallory S. Laser photocoagulation of superficial proliferating hemangiomas.  J Dermatol Surg Oncol. 1994;  20(1) 43-46
    PubMedGoogle Scholar
  • 105 Batta K, Goodyear H, Moss C et al.. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis.  Lancet. 2002;  360(9332) 521-527
    CrossrefPubMedGoogle Scholar
  • 106 Burrows P E, Rosenberg H, Chuang H. Diffuse hepatic hemangiomas: percutaneous transcatheter embolization with detachable silicone balloons.  Radiology. 1985;  156(1) 85-88
    PubMedGoogle Scholar
  • 107 Johnson D H, Vinson A M, Wirth F H et al.. Management of hepatic hemangioendotheliomas of infancy by transarterial embolization: a report of two cases.  Pediatrics. 1984;  73(4) 546-549
    PubMedGoogle Scholar
  • 108 Warmann S, Bertram H, Kardorff R et al.. Interventional treatment of infantile hepatic hemangioendothelioma.  J Pediatr Surg. 2003;  38(8) 1177-1181
    CrossrefPubMedGoogle Scholar
  • 109 Holcomb 3rd G W, O'Neill Jr J A, Mahboubi S, Bishop H C. Experience with hepatic hemangioendothelioma in infancy and childhood.  J Pediatr Surg. 1988;  23(7) 661-666
    PubMedGoogle Scholar
  • 110 Stanley P, Grinnell V, Stanton R, Williams K, Shore N. Therapeutic embolization of infantile hepatic hemangioma with polyvinyl alcohol.  AJR Am J Roentgenol. 1983;  141(5) 1047-1051
    PubMedGoogle Scholar
  • 111 Jianhong L, Xianliang H, Xuewu J. Transcatheter arterial embolization in the treatment of extensive maxillofacial hemangioma in children.  World J Surg. 2005;  29(12) 1550-1556
    CrossrefPubMedGoogle Scholar
  • 112 Andronikou S, Mandelstam S, Fasulakis S. MRI and preoperative embolization of a nasal cavity haemangioma in a child.  Australas Radiol. 2003;  47(4) 386-388
    CrossrefPubMedGoogle Scholar
  • 113 Konior R J, Holinger L D, Russell E J. Superselective embolization of laryngeal hemangioma.  Laryngoscope. 1988;  98(8 Pt 1) 830-834
    PubMedGoogle Scholar
  • 114 Burrows P E, Lasjaunias P, Ter Brugge K, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results.  Pediatrics. 1987;  80(3) 386-394
    PubMedGoogle Scholar
  • 115 Kaneko R, Tohnai I, Ueda M et al.. Curative treatment of central hemangioma in the mandible by direct puncture and embolisation with n-butyl-cyanoacrylate (NBCA).  Oral Oncol. 2001;  37(7) 605-608
    CrossrefPubMedGoogle Scholar
  • 116 O'Donovan J C, Donaldson J S, Morello F P et al.. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate.  AJR Am J Roentgenol. 1997;  169(3) 723-729
    PubMedGoogle Scholar
  • 117 Hayashi N, Masumoto T, Okubo T et al.. Hemangiomas in the face and extremities: MR-guided sclerotherapy–optimization with monitoring of signal intensity changes in vivo.  Radiology. 2003;  226(2) 567-572
    CrossrefPubMedGoogle Scholar
  • 118 Winter H, Dräger E, Sterry W. Sclerotherapy for treatment of hemangiomas.  Dermatol Surg. 2000;  26(2) 105-108
    CrossrefPubMedGoogle Scholar
  • 119 Zukerberg L R, Nickoloff B J, Weiss S W. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis.  Am J Surg Pathol. 1993;  17(4) 321-328
    PubMedGoogle Scholar
  • 120 Lyons L L, North P E, Mac-Moune Lai F et al.. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.  Am J Surg Pathol. 2004;  28(5) 559-568
    CrossrefPubMedGoogle Scholar
  • 121 Enjolras O, Mulliken J, Wassef M et al.. Residual lesions after Kasabach-Merritt phenomenon in 41 patients.  J Am Acad Dermatol. 2000;  42(2 Pt 1) 225-235
    CrossrefPubMedGoogle Scholar
  • 122 Gruman A, Liang M, Mulliken J et al.. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.  J Am Acad Dermatol. 2005;  52(4) 616-622
    CrossrefPubMedGoogle Scholar
  • 123 Hauer J, Graubner U, Konstantopoulos N et al.. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.  Pediatr Blood Cancer. 2007;  49(6) 852-854
    CrossrefPubMedGoogle Scholar
  • 124 Harper L, Michel J, Enjolras O et al.. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.  Eur J Pediatr Surg. 2006;  16(5) 369-372
    Article in Thieme ConnectPubMedGoogle Scholar
  • 125 Haisley-Royster C, Enjolras O, Frieden I et al.. Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine.  J Pediatr Hematol Oncol. 2002;  24(6) 459-462
    CrossrefPubMedGoogle Scholar

Sandeep VaidyaM.D. 

Assistant Professor, Department of Radiology, University of Washington

1959 NE Pacific Street, Box #357115, Seattle, WA 98195

Email: svaidya@u.washington.edu